Form 4: Evolent Health's General Counsel, Jonathan Weinberg, Executes Stock Options Under 10b5-1 Plan

Jonathan Weinberg, General Counsel of Evolent Health, executed stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Summary

• On August 22, 2024, Jonathan Weinberg, General Counsel of Evolent Health, Inc., executed transactions involving Class A Common Stock.
• These transactions included the exercise of stock options and the sale of shares, all conducted under a Rule 10b5-1 trading plan adopted on February 28, 2024.
• Weinberg exercised options to acquire 25,253 shares at $13.95 and 16,887 shares at $17.
• He then sold 25,253 shares at $32 and 16,887 shares at $30.
• Following these transactions, Weinberg directly owns 167,027 shares of Class A Common Stock.
• The exercised options had vested on various dates between February 1, 2019, and June 4, 2019.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine insider trading activity under a pre-arranged plan. There is no indication of positive or negative implications for the company's performance.

Positives

• The transactions were executed under a pre-existing 10b5-1 trading plan, indicating a planned and transparent approach to stock transactions.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan suggests no material impact is expected.

Key Dates